The pharmaceutical sector is seeing a important shift in glucose therapy with the emergence of GLP-1 patches. These groundbreaking methods offer a potentially simple choice to needle injections for individuals managing diabetes. By bypassing the necessity for frequent pokes, GLP-1 skin devices pr